Epidemiology of urothelial carcinoma J Miyazaki, H Nishiyama International journal of urology 24 (10), 730-734, 2017 | 254 | 2017 |
B acillus C almette–G uerin (BCG) immunotherapy for bladder cancer: Current understanding and perspectives on engineered BCG vaccine K Kawai, J Miyazaki, A Joraku, H Nishiyama, H Akaza Cancer science 104 (1), 22-27, 2013 | 219 | 2013 |
Nanoparticulation of BCG-CWS for application to bladder cancer therapy T Nakamura, M Fukiage, M Higuchi, A Nakaya, I Yano, J Miyazaki, ... Journal of controlled release 176, 44-53, 2014 | 86 | 2014 |
Type 1, P and S fimbriae, and afimbrial adhesin I are not essential for uropathogenic Escherichia coli to adhere to and invade bladder epithelial cells J Miyazaki, W Ba-Thein, T Kumao, M Obata Yasuoka, H Akaza, H Hayshi FEMS Immunology & Medical Microbiology 33 (1), 23-26, 2002 | 78 | 2002 |
The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma J Miyazaki, H Nishiyama, I Yano, A Nakaya, H Kohama, K Kawai, ... Anticancer research 31 (6), 2065-2071, 2011 | 49 | 2011 |
Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette‐Guérin through Toll‐like receptor signalling J Miyazaki, K Kawai, T Oikawa, A Johraku, K Hattori, T Shimazui, H Akaza BJU international 97 (4), 860-864, 2006 | 45 | 2006 |
Biomarkers for precision medicine in bladder cancer T Kojima, K Kawai, J Miyazaki, H Nishiyama International journal of clinical oncology 22, 207-213, 2017 | 44 | 2017 |
Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer M Nozawa, H Mukai, S Takahashi, H Uemura, T Kosaka, Y Onozawa, ... International journal of clinical oncology 20, 1026-1034, 2015 | 42 | 2015 |
Identification of a type III secretion system in uropathogenic Escherichia coli J Miyazaki, W Ba-Thein, T Kumao, H Akaza, H Hayashi FEMS microbiology letters 212 (2), 221-228, 2002 | 40 | 2002 |
Occurrence of infection following prostate biopsy procedures in Japan: Japanese Research Group for Urinary Tract Infection (JRGU)–a multi-center retrospective study Y Togo, T Kubo, R Taoka, Y Hiyama, T Uehara, J Hashimoto, Y Kurimura, ... Journal of Infection and Chemotherapy 20 (4), 232-237, 2014 | 39 | 2014 |
Laparoscopic versus open nephroureterectomy in muscle-invasive upper tract urothelial carcinoma: subanalysis of the multi-institutional national database of the Japanese … J Miyazaki, H Nishiyama, H Fujimoto, C Ohyama, T Koie, S Hinotsu, ... Journal of endourology 30 (5), 520-525, 2016 | 33 | 2016 |
Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor M Kurobe, K Kawai, T Oikawa, D Ichioka, S Kandori, E Takaoka, T Kojima, ... Journal of Cancer Research and Clinical Oncology 141, 127-133, 2015 | 31 | 2015 |
Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy T Kimura, M Onozawa, J Miyazaki, T Matsuoka, A Joraku, K Kawai, ... International Journal of Urology 21 (6), 578-583, 2014 | 31 | 2014 |
Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era E Takaoka, Y Matsui, T Inoue, J Miyazaki, M Nakashima, T Kimura, ... Japanese journal of clinical oncology 43 (4), 404-409, 2013 | 29 | 2013 |
Immunoprotection against murine bladder carcinoma by octaarginine‐modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette‐Guérin A Joraku, A Homhuan, K Kawai, T Yamamoto, J Miyazaki, K Kogure, ... BJU international 103 (5), 686-693, 2009 | 29 | 2009 |
Mechanism responsible for the antitumor effect of BCG-CWS using the LEEL method in a mouse bladder cancer model T Nakamura, M Fukiage, Y Suzuki, I Yano, J Miyazaki, H Nishiyama, ... Journal of controlled release 196, 161-167, 2014 | 28 | 2014 |
Bacillus Calmette–Guérin strain differences as the basis for immunotherapies against bladder cancer J Miyazaki, M Onozawa, E Takaoka, I Yano International Journal of Urology 25 (5), 405-413, 2018 | 24 | 2018 |
Analysis of intravesical recurrence after bladder-preserving therapy for muscle-invasive bladder cancer M Onozawa, N Miyanaga, S Hinotsu, J Miyazaki, T Oikawa, T Kimura, ... Japanese journal of clinical oncology 42 (9), 825-830, 2012 | 24 | 2012 |
The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study J Miyazaki, M Onozawa, S Takahashi, Y Maekawa, M Yasuda, K Wada, ... BMC urology 19, 1-9, 2019 | 23 | 2019 |
Second nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by Japanese Surveillance Committee from 2015 to 2016 … H Hayami, S Takahashi, K Ishikawa, M Yasuda, S Yamamoto, K Wada, ... Journal of Infection and Chemotherapy 25 (6), 413-422, 2019 | 23 | 2019 |